Elanco Animal Health Incorporated beat EPS estimates 88% of the time across 16 reported quarters (14 beats, 2 misses), averaging +25.6% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.27 | $0.34 | +25.9% | Beat | Q2 FY26 call |
| Q1 FY26 | $0.34 | $0.40 | +17.6% | Beat | |
| Q4 FY25 | $0.11 | $0.13 | +18.2% | Beat | Q4 FY25 call |
| Q3 FY25 | $0.13 | $0.19 | +46.1% | Beat | |
| Q2 FY25 | $0.20 | $0.26 | +30.0% | Beat | |
| Q1 FY25 | $0.31 | $0.37 | +19.4% | Beat | |
| Q4 FY24 | $0.15 | $0.14 | -6.7% | Miss | |
| Q3 FY24 | $0.12 | $0.13 | +8.3% | Beat | |
| Q2 FY24 | $0.24 | $0.30 | +25.0% | Beat | |
| Q1 FY24 | $0.26 | $0.34 | +30.8% | Beat | |
| Q4 FY23 | $0.10 | $0.08 | -20.0% | Miss | |
| Q3 FY23 | $0.12 | $0.18 | +50.0% | Beat |
Back to ELAN overview · ELAN holders · ELAN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.